(Q44646836)

5 December 2017

title

The role of metallothionein II in neuronal differentiation and survival (English)

1 reference

5 December 2017

4

Milena Penkowa

0 references

author name string

Vladimir Berezin

2

1 reference

5 December 2017

Elisabeth Bock

3

1 reference

5 December 2017

Lene B. Køhler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14604781

29 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

5 December 2017

28 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14604781

full work available at URL

29 March 2024

https://api.elsevier.com/content/article/PII:S0006899303036436?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

https://api.elsevier.com/content/article/PII:S0006899303036436?httpAccept=text/plain

29 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

29 March 2024

1 reference

5 December 2017

volume

992

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

128-136

1 reference

Treatment with metallothionein prevents demyelination and axonal damage and increases oligodendrocyte precursors and tissue repair during experimental autoimmune encephalomyelitis

5 December 2017

cites work

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1002/JNR.10615

Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington's disease.

1

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Aggravation of 6-hydroxydopamine-induced dopaminergic lesions in metallothionein-I and -II knock-out mouse brain

29 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Metallothionein (MT) isoforms in the central nervous system (CNS): regional and cell-specific distribution and potential functions as an antioxidant

29 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Growth of pyramidal, but not non-pyramidal, dendrites in long-term organotypic explants of neonatal rat neocortex chronically exposed to neurotrophin-3.

29 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Oxidatively modified proteins in aging and disease

29 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Enhanced seizures and hippocampal neurodegeneration following kainic acid-induced seizures in metallothionein-I + II-deficient mice

29 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration

29 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Role of metallothioneins in peripheral nerve function and regeneration.

29 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Overexpression of metallothionein in pancreatic beta-cells reduces streptozotocin-induced DNA damage and diabetes

29 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

29 March 2024

Zinc and brain injury

11

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Metallothionein-IIA promotes initial neurite elongation and postinjury reactive neurite growth and facilitates healing after focal cortical brain injury.

29 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Metallothionein: the multipurpose protein

29 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Transgenic mice that overexpress metallothionein-I resist dietary zinc deficiency

29 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

The role of phosphatidylinositol 3-kinase in neural cell adhesion molecule-mediated neuronal differentiation and survival

29 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

CAM-FGF receptor interactions: a model for axonal growth

29 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity.

29 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Why are growth factors important in oligodendrocyte physiology?

29 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Neurotrophins and their receptors in nerve injury and repair.

29 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Neuroinflammatory processes are important in neurodegenerative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development

29 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Why does remyelination fail in multiple sclerosis?

29 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Transcriptional induction of metallothionein-I and -II genes in the livers of Cu,Zn-superoxide dismutase knockout mice.

29 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier

29 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Metallothionein-1+2 Protect the CNS after a Focal Brain Injury

29 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

In vivo actions of fibroblast growth factor-2 and insulin-like growth factor-I on oligodendrocyte development and myelination in the central nervous system

29 March 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment

29 March 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Roles of the metallothionein family of proteins in the central nervous system

29 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

L1 neural cell adhesion molecule is a survival factor for fetal dopaminergic neurons

29 March 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Metallothionein-III antagonizes the neurotoxic and neurotrophic effects of amyloid beta peptides

29 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Metallothionein I and II protect against zinc deficiency and zinc toxicity in mice

29 March 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis.

29 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Free radical scavenging actions of hippocampal metallothionein isoforms and of antimetallothioneins: an electron spin resonance spectroscopic study

29 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

The protein thiol metallothionein as an antioxidant and protectant against antineoplastic drugs

29 March 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Rat models as tool to develop new immunotherapies

29 March 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

29 March 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Extracellular metallothionein effects on lymphocyte activities

29 March 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Characterization of microwell cultures of dissociated brain tissue for studies of cell-cell interactions

29 March 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Cytokines in inflammatory brain lesions: helpful and harmful

29 March 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Induction, regulation, degradation, and biological significance of mammalian metallothioneins.

29 March 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes

29 March 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Zinc sulphate induces metallothionein in pancreatic islets of mice and protects against diabetes induced by multiple low doses of streptozotocin

29 March 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Increased demyelination and axonal damage in metallothionein I+II-deficient mice during experimental autoimmune encephalomyelitis.

29 March 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Protective effect of platelet-derived growth factor against 6-hydroxydopamine-induced lesion of rat dopaminergic neurons in culture.

29 March 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Alzheimer's disease and oxygen radicals: new insights

29 March 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Metallothionein induced by cadmium or zinc inhibits lipid peroxidation in rats exposed to dimethylnitrosamine

29 March 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Identification of a neuritogenic ligand of the neural cell adhesion molecule using a combinatorial library of synthetic peptides.

29 March 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

A simple procedure for quantification of neurite outgrowth based on stereological principles.

29 March 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice.

29 March 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Neurotrophins reduce degeneration of injured ascending sensory and corticospinal motor axons in adult rat spinal cord

29 March 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide

29 March 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Preferential Zn2+ influx through Ca2+-permeable AMPA/kainate channels triggers prolonged mitochondrial superoxide production

29 March 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Zinc-induced cortical neuronal death: contribution of energy failure attributable to loss of NAD(+) and inhibition of glycolysis

29 March 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Cofactors of mitochondrial enzymes attenuate copper-induced death in vitro and in vivo

29 March 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Metallothionein induction in rat liver by dietary restriction or exercise and reduction of exercise-induced hepatic lipid peroxidation

29 March 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Yeast and mammalian metallothioneins functionally substitute for yeast copper-zinc superoxide dismutase

29 March 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Evidence for a protective role of metallothionein-1 in focal cerebral ischemia

29 March 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Antioxidant role of metallothioneins: a comparative overview

29 March 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system

29 March 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Automated in vitro screening of teratogens

29 March 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Immunomodulatory activities of extracellular metallothionein. II. Effects on macrophage functions

29 March 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

Metallothionein suppresses collagen-induced arthritis via induction of TGF-beta and down-regulation of proinflammatory mediators

29 March 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

A Novel Function of Monomeric Amyloid β-Protein Serving as an Antioxidant Molecule against Metal-Induced Oxidative Damage

29 March 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.049

29 March 2024

Identifiers

1 reference

5 December 2017

1 reference